Short Interest in Cingulate Inc. (NASDAQ:CINGW) Expands By 393.4%

Cingulate Inc. (NASDAQ:CINGW) was the target of a large increase in short interest in the month of February. As of February 27th, there was short interest totaling 2,467 shares, an increase of 393.4% from the February 12th total of 500 shares. Based on an average daily volume of 32,769 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 32,769 shares, the short-interest ratio is currently 0.1 days.

Cingulate Trading Down 9.3%

Shares of Cingulate stock traded down $0.01 during trading hours on Thursday, reaching $0.05. 12,724 shares of the stock traded hands, compared to its average volume of 56,687. Cingulate has a one year low of $0.02 and a one year high of $0.18. The company has a 50 day moving average price of $0.07 and a 200 day moving average price of $0.06.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.